メインコンテンツに移動


Join us to explore how our API expertise can help you drive success

April 17Th - 19Th, 2024
|
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan

Contact Us
Verified

Our Team at CPHI Japan 2024

About CPHI Japan 2024

CPHI Japan 2024 is a leading annual trade event focusing on the pharmaceutical industry in Japan. Held at the Tokyo Big Sight (East Halls 4, 5 & 6) from April 17th to 19th, 2024, the event brings together a comprehensive range of exhibitors and attendees from across the pharmaceutical supply chain.

Attendees can expect to:

  • Explore the latest advancements and solutions showcased by exhibitors covering pharma ingredients, outsourcing services, biopharmaceuticals, pharmaceutical machinery & equipment, and drug delivery systems & packaging.
  • Network with industry professionals from Japan and around the world, fostering potential business partnerships.
  • Gain valuable knowledge through conferences and presentations delivered by industry experts, staying abreast of current trends and insights within the Japanese pharmaceutical market.

CPHI Japan 2024 serves as a platform for industry stakeholders to connect, exchange information, and explore business opportunities within the Japanese pharmaceutical landscape.

 

About Dr.Reddy's API Business

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 180+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom

About Graph

About Graph

Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.

ENQUIRE NOW

Sustainability

Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.

Sustainability

Our Achievements

Our Plants

Dr. Reddy’s API  Manufacturing Locations

Company

© 2024 Dr. Reddy’s Laboratories Ltd. All rights reserved.

免責事項

このウェブサイト上のいかなる情報も、製品またはサービスへの言及を含め、販売の申し出を構成するものではなく、販売の申し出を表すものと解釈されるものでもありません。有効な特許により保護されている製品は、商用目的で提供または提供されるものではありません。ただし、特定のケースでは、Dr. Reddy の独自の裁量により、現地の法的要件に従って、そのような製品の研究用数量が、規制免除が存在する場所に、インド特許法第 107A 条 (Bolar 免除) に基づく規制提出の目的で提供される場合があります。購入者は、それぞれの市場における特許シナリオを含む製品またはサービスについて独自の評価を行う必要があり、すべての特許関連法的責任を負うことになります。Dr. Reddy は、商品性、特定目的への適合性、および非侵害の保証を含むがこれらに限定されない、明示または黙示を問わずすべての保証を否認します。